Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Glioblastoma × rindopepimut × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 3 Expanded_access 1

Sponsor

Cancer Type

Conditions

Interventions

ulixertinib 1 rindopepimut 1 pembrolizumab 1 mogamulizumab 1 efineptakin alfa 1 Proton Pump Inhibitors 1 Ipilimumab 1 Hydrocortisone 1 Cancer Vaccines 1 Adjuvants, Immunologic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03068650 2017-10-18

CDX-110

Celldex Therapeutics

No longer available

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡